Lineage Cell Therapeutics Inc. logo

Lineage Cell Therapeutics Inc. (BT3)

Market Closed
16 Oct, 08:00 PM
XFRA XFRA
€
0. 86
+0.06
+7.9345%
€
- Market Cap
- P/E Ratio
- Div Yield
1,100 Volume
-0.11 Eps
€ 0.79
Previous Close
Add Transaction
Day Range
0.86 0.86
Year Range
0.78 1.69
Want to track BT3 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Name Exchange Split Ratio
Lineage Cell Therapeutics Inc. logo
BT3 Lineage Cell Therapeutics Inc.
25 Nov 2019
XFRA
1:3

BT3 Stock Split FAQ

When was the last stock split?

The last stock split occurred on 2019-11-25, with a 1.0 to 3.0 split ratio, based on the BT3's announcement.

What was the stock exchange for the split?

The most recent stock split took place on the XFRA exchange.